
Boylston Properties Proposes West Cambridge Apartment Tower
The plans for a 236-unit apartment complex in West Cambridge illustrates Greater Boston’s shifting development economics.
The plans for a 236-unit apartment complex in West Cambridge illustrates Greater Boston’s shifting development economics.
MBTA officials began the formal redevelopment process for Cambridge’s Alewife station, asking for private joint partners capable of building a “world-class public transportation hub.”
The MBTA will seek private developers to demolish the Alewife station parking garage in West Cambridge and partner on a major transit-oriented project at the northern end of the Red Line.
Moderna’ new global headquarters in Cambridge’s Kendall Square is set for delivery in November under budget, developer Alexandria Real Estate Equities announced.
Cambridge-based Trinity Property Management proposes demolishing The Garage office-retail complex and construction of a new 6-story, 87,000-square-foot building at the corner of JFK and Mount Auburn streets.
Lesley University is the latest local higher ed institution tapping into its real estate assets for financial gain, listing a cluster of parcels between Harvard and Porter Squares in Cambridge for sale.
Moderna Pharmaceuticals has leased 462,000 square feet at Alexandria Real Estate Equities’ 325 Binney St. in Cambridge for a new headquarters and R&D facility.
The 475,000-square-foot Sullivan Courthouse redevelopment in East Cambridge will be ready for occupancy in fall 2023 after the addition of a new investor, developers said.
Developers of a proposed 100-percent affordable housing project in Cambridge’s Porter Square are rethinking their plans after withdrawing the 48-unit project days ahead of a crucial board vote.
Construction crews topped off the first residential building built at Cambridge Crossing under DivcoWest’s ownership, a 468-unit tower known as Park 151.
Lamplighter Brewing Co. will open a tap room and production space at Cambridge Crossing this summer after revising plans in the wake of the pandemic.
With an additional 113,000-square-foot commitment, Bristol Myers Squibb has spoken for all of the office-lab space in DivcoWest’s 250 Water St. development at Cambridge Crossing.
A Cambridge-based nonprofit will lead the programming of performance and arts space at a new office-lab building proposed by BioMed Realty in Kendall Square.
A Cambridge research institute that’s collaborating with Johnson & Johnson on its COVID-19 vaccine candidate is proposing a 186,000-square-foot R&D complex near Kendall Square.
Massachusetts Institute for Technology has unveiled plans for a 174,000-square-foot development to house its newly formed hub for computer science, artificial intelligence and data science programs.
A life science developer that made its first Greater Boston acquisition in February has expanded its local portfolio with the $54 million acquisition of a transit-oriented property in West Cambridge.
MIT’s redevelopment of the Volpe Center property still includes plans for the tallest building in Cambridge – but well short of the 500 feet allowed by zoning.
A two-building commercial property on the outskirts of Harvard Square has been sold for $16.1 million to a Cambridge-based developer.